These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 20702826
1. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D. Invest Ophthalmol Vis Sci; 2011 Jan 05; 52(1):80-6. PubMed ID: 20702826 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Chang-Lin JE, Burke JA, Peng Q, Lin T, Orilla WC, Ghosn CR, Zhang KM, Kuppermann BD, Robinson MR, Whitcup SM, Welty DF. Invest Ophthalmol Vis Sci; 2011 Jun 28; 52(7):4605-9. PubMed ID: 21421864 [Abstract] [Full Text] [Related]
7. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera. Meyer CH, Klein A, Alten F, Liu Z, Stanzel BV, Helb HM, Brinkmann CK. Retina; 2012 Jun 28; 32(10):2133-40. PubMed ID: 23060033 [Abstract] [Full Text] [Related]
8. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Fialho SL, Rêgo MB, Siqueira RC, Jorge R, Haddad A, Rodrigues AL, Maia-Filho A, Silva-Cunha A. Curr Eye Res; 2006 Jun 28; 31(6):525-34. PubMed ID: 16769612 [Abstract] [Full Text] [Related]
9. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide. Hou H, Wang C, Nan K, Freeman WR, Sailor MJ, Cheng L. Invest Ophthalmol Vis Sci; 2016 Feb 28; 57(2):557-66. PubMed ID: 26882530 [Abstract] [Full Text] [Related]
10. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye. Sigurdsson HH, Konráethsdóttir F, Loftsson T, Stefánsson E. Acta Ophthalmol Scand; 2007 Sep 28; 85(6):598-602. PubMed ID: 17645424 [Abstract] [Full Text] [Related]
13. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB, Miller M. Ophthalmology; 2003 Apr 28; 110(4):681-6. PubMed ID: 12689886 [Abstract] [Full Text] [Related]
15. Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits. Wang M, Liu W, Lu Q, Zeng H, Liu S, Yue Y, Cheng H, Liu Y, Xue M. Retina; 2012 Apr 28; 32(10):2158-64. PubMed ID: 23099451 [Abstract] [Full Text] [Related]
17. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation. Prieto E, Cardiel MJ, Vispe E, Idoipe M, Garcia-Martin E, Fraile JM, Polo V, Mayoral JA, Pablo LE, Rodrigo MJ. Biomed Mater; 2020 Nov 21; 15(6):065021. PubMed ID: 32647098 [Abstract] [Full Text] [Related]
19. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits. Kane FE, Green KE. J Ocul Pharmacol Ther; 2015 Feb 21; 31(1):11-6. PubMed ID: 25562126 [Abstract] [Full Text] [Related]
20. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. Loftsson T, Hreinsdóttir D, Stefánsson E. J Pharm Pharmacol; 2007 May 21; 59(5):629-35. PubMed ID: 17524227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]